University of the Witwatersrand

Sinéad Delany-Moretlwe has been selected as a co-principal investigator for the groundbreaking HIV Prevention Trials Network (HPTN). HPTN is a collaborative clinical trials network with 67 sites in North and South America, Africa and…

Combining genomic data and human travel patterns in South Africa has revealed key insights into the spread, evolution, and resistance patterns of a major bacterium behind pneumonia and meningitis globally. The approach combines a…

Dr Tiisetso E Lephoto, Associate Professor Claudia Polese, Dr June Fabian, Professor Irvy (Igle) Gledhill, and Professor Jennifer Fitchett were winners in their categories, announced at a glittering ceremony hosted simultaneously in…

Peco Power, a trailblazer in sustainable energy solutions developed at Wits University, recently introduced this innovative approach, a Rent-to-Own Electricity and Champion Model, to the Nomzamo Agricultural Village in Ermelo in Mpumalanga,…

Hosted by Wits University’s Tshimologong Digital Innovation Precinct, the week-long workshop is one of the outcomes of the robust partnership through years of collaboration between the Universities of the Witwatersrand and Edinburgh.…

The Civic Leadership Programme (CLP), offered by Wits Citizenship and Community Outreach (WCCO) and the Auwal Socio-Economic Research Institute (ASRI), is transforming students into active, ethical leaders ready to address South Africa's…

The paper from the BePRECISE consortium describes comprehensive guidelines aimed at improving the accuracy, safety, and health equity in precision medicine. BePRECISE is Better Precision-data Reporting of Evidence from Clinical…

In a critical global public health development, a candidate vaccine for tuberculosis (TB) has been created using a gene-editing approach. TB remains the leading cause of death by infectious disease globally, with South Africa having one…

The Wits Reproductive Health and HIV Institute (Wits RHI) co-managed the Wits RHI Research Centre Clinical Research site in Hillbrow, Johannesburg, in South Africa, where 212 young women were enrolled. The groundbreaking results from…

She joins fellow Principal Investigator, Professor Willem Hanekom from the Africa Health Research Institute (AHRI), who will lead the large Phase 3 trial that will evaluate whether the M72/AS01E vaccine candidate can protect older…